BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 32189595)

  • 1. Liver Fibrosis in Rheumatoid Arthritis Patients Treated with Methotrexate.
    Hilal G; Akasbi N; Boudouaya H; Salma K; Harzy T
    Curr Rheumatol Rev; 2020; 16(4):293-297. PubMed ID: 32189595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
    Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
    Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate therapy is not associated with increased liver stiffness and significant liver fibrosis in rheumatoid arthritis patients: A cross-sectional controlled study with real-time two-dimensional shear wave elastography.
    Erre GL; Cadoni ML; Meloni P; Castagna F; Mangoni AA; Piga M; Passiu G; Carru C; Zinellu A; Vidili G
    Eur J Intern Med; 2019 Nov; 69():57-63. PubMed ID: 31474422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate does not increase the risk of liver fibrosis in patients with rheumatoid arthritis: assessment by ultrasound elastography (ARFI-MetRA study).
    Feuchtenberger M; Kraus L; Nigg A; Schulze-Koops H; Schäfer A
    Rheumatol Int; 2021 Jun; 41(6):1079-1087. PubMed ID: 33608744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Substantial Liver Fibrosis by Real-time Shear Wave Elastography in Methotrexate-Treated Patients With Rheumatoid Arthritis.
    Kim TY; Kim JY; Sohn JH; Lee HS; Bang SY; Kim Y; Kim MY; Jeong WK
    J Ultrasound Med; 2015 Sep; 34(9):1621-30. PubMed ID: 26269292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of liver fibrosis induced by methotrexate and other rheumatoid arthritis medications according to the Fibrosis-4 Index.
    Avouac J; Degrave R; Vergneault H; Combier A; Wanono S; Boisson M; Frantz C; Allanore Y
    Clin Exp Rheumatol; 2022 Jan; 40(1):150-157. PubMed ID: 33938795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of liver fibrosis by Fibroscan in patients on long-term methotrexate therapy for rheumatoid arthritis.
    Bafna P; Sahoo RR; Hazarika K; Manoj M; Rungta S; Wakhlu A
    Clin Rheumatol; 2021 Sep; 40(9):3605-3613. PubMed ID: 33686476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated.
    Atallah E; Grove JI; Crooks C; Burden-Teh E; Abhishek A; Moreea S; Jordan KM; Ala A; Hutchinson D; Aspinall RJ; Murphy R; Aithal GP
    J Hepatol; 2023 May; 78(5):989-997. PubMed ID: 36702175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Security of the combined treatment of methotrexate and leflunomide in patients with rheumatoid arthritis].
    Nesa L; Gobbi C; Alba P; Exeni I; Babini A; Albiero E
    Rev Fac Cien Med Univ Nac Cordoba; 2007; 64(4):109-14. PubMed ID: 19928400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between Cumulative Methotrexate Dose, Metabolic Syndrome and Hepatic Fibrosis Detected by FibroScan in Rheumatoid Arthritis Patients.
    Lertnawapan R; Chonprasertsuk S; Siramolpiwat S; Jatuworapruk K
    Medicina (Kaunas); 2023 May; 59(6):. PubMed ID: 37374233
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of methotrexate on gastrointestinal symptoms in patients with rheumatoid arthritis.
    Asai S; Nagai K; Takahashi N; Watanabe T; Matsumoto T; Asai N; Sobue Y; Ishiguro N; Kojima T
    Int J Rheum Dis; 2019 Feb; 22(2):207-213. PubMed ID: 30168274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic and hematological adverse effects of long-term low-dose methotrexate therapy in rheumatoid arthritis: An observational study.
    Dubey L; Chatterjee S; Ghosh A
    Indian J Pharmacol; 2016; 48(5):591-594. PubMed ID: 27721549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
    Müller RB; von Kempis J; Haile SR; Schiff MH
    Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Safety of methotrexate in rheumatoid arthritis: a retrospective cohort study in clinical practice].
    La Montagna G; Tirri R; Vitello R; Malesci D; Buono R; Mennillo G; Valentini G
    Reumatismo; 2006; 58(4):261-7. PubMed ID: 17216014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate is not associated with increased liver cirrhosis in a population-based cohort of rheumatoid arthritis patients with chronic hepatitis B.
    Tang KT; Hung WT; Chen YH; Lin CH; Chen DY
    Sci Rep; 2016 Mar; 6():22387. PubMed ID: 26928373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
    Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A
    Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver stiffness correlates with methotrexate cumulative dose in patients with rheumatoid arthritis.
    Arena U; Stasi C; Mannoni A; Benucci M; Maddali-Bongi S; Cammelli D; Assarat A; Marra F; Pinzani M
    Dig Liver Dis; 2012 Feb; 44(2):149-53. PubMed ID: 21930442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors associated with the cumulative survival of low-dose methotrexate in 273 Japanese patients with rheumatoid arthritis.
    Ideguchi H; Ohno S; Ishigatsubo Y
    J Clin Rheumatol; 2007 Apr; 13(2):73-8. PubMed ID: 17414533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.
    Zintzaras E; Dahabreh IJ; Giannouli S; Voulgarelis M; Moutsopoulos HM
    Clin Ther; 2008 Nov; 30(11):1939-55. PubMed ID: 19108784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-Regression of a Dose-Response Relationship of Methotrexate in Mono- and Combination Therapy in Disease-Modifying Antirheumatic Drug-Naive Early Rheumatoid Arthritis Patients.
    Bergstra SA; Allaart CF; Stijnen T; Landewé RBM
    Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1473-1483. PubMed ID: 27992656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.